Close
Open Nav

 

Monday, October 21, 2019 | 1:00pm - 6:30pm

The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.

The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties. 

Participation in the BIO SPARK Showcase is free. Sign up here to register for the BIO SPARK Showcase.

2019 BIO SPARK Showcase Presentation Schedule

Time

Spark Affiliate and Program

1:00 PM - 1:10 PM
Welcome from SPARK Translational Research Program, Stanford Medicine
  • Kevin Grimes, MD, Co-Director
 
1:10 PM - 1:30 PM
SPARK at Stanford
Novel Treatment for Kidney Cancer
Arvin Gouw 
 
1:30 PM - 1:50 PM
SPARK Taiwan
Selective Top2 Chemotherapeutics
TBD
 
1:50 PM - 2:10 PM
SPARK Norway
Novel Therapy for Ischemic Reperfusion
TBD
 
2:10 PM - 2:30 PM
SPARK Japan
Revolutionizing the way we treat heart failure
TBD

 

 
2:30 PM - 2:40 PM
Break
 
2:40 PM - 3:00 PM
SPARK Japan
Gene engineering tools for optical control of CRISPR/Cas9·Cpf1, Cre-loxP system
TBD
 
3:00 PM - 3:20 PM
SPARK Norway
A novel vaccine platform against influenza
Gunnveig Grødeland
 
3:20 PM - 3:40 PM
Stanford University
Small Molecule for the treatment of Type 1 Diabetes
Andy Wardle
 
3:40 PM - 4:00 PM
SPARK Germany
Recombinant human Neuregulin1 (rhNRG1) for the treatment of Schwann cell-‐derived nerve sheath tumors
Helen Morrison
 
4:00 PM - 4:10 PM
Break
 
4:10 PM - 4:30 PM
SPARK Stanford 
Transient telomere extension to treat liver failure in dyskeratosis congenita patients
John Ramunas
 
4:30 PM - 4:50 PM
SPARK Finland
Novel treatment modality for Limbal Epithelial Stem Cell Deficiency
Anni Mörö
 
4:50 PM - 5:10 PM
SPARK Norway
Repositioning of existing drugs to Prevent ventricular arrhythmias
TBD
 
5:10 PM - 5:30 PM
SPARK at Stanford
Charge-Altering Releasable Transporters (CARTS): New Materials enable a New Platform Technology for Gene Delivery, Vaccinations, and Cancer Immunotherapy
Tim Blake
 
5:30 PM - 6:30 PM
Reception